Cargando…

A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions

It is meaningful to assess the risk of cancer incidence among patients with precancerous colorectal lesions. Comparing the within-sample relative expression orderings (REOs) of colorectal cancer patients measured by multiple platforms with that of normal colorectal tissues, a qualitative transcripti...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Qingzhou, Zeng, Qiuhong, Jiang, Weizhong, Xie, Jiajing, Cheng, Jun, Yan, Haidan, He, Jun, Xu, Yang, Guan, Guoxian, Guo, Zheng, Ao, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844367/
https://www.ncbi.nlm.nih.gov/pubmed/33519891
http://dx.doi.org/10.3389/fgene.2020.573787
_version_ 1783644331217780736
author Guan, Qingzhou
Zeng, Qiuhong
Jiang, Weizhong
Xie, Jiajing
Cheng, Jun
Yan, Haidan
He, Jun
Xu, Yang
Guan, Guoxian
Guo, Zheng
Ao, Lu
author_facet Guan, Qingzhou
Zeng, Qiuhong
Jiang, Weizhong
Xie, Jiajing
Cheng, Jun
Yan, Haidan
He, Jun
Xu, Yang
Guan, Guoxian
Guo, Zheng
Ao, Lu
author_sort Guan, Qingzhou
collection PubMed
description It is meaningful to assess the risk of cancer incidence among patients with precancerous colorectal lesions. Comparing the within-sample relative expression orderings (REOs) of colorectal cancer patients measured by multiple platforms with that of normal colorectal tissues, a qualitative transcriptional signature consisting of 1,840 gene pairs was identified in the training data. Within an evaluation dataset of 16 active and 18 inactive (remissive) ulcerative colitis subjects, the median incidence risk score of colorectal carcinoma was 0.6402 in active ulcerative colitis subjects, significantly higher than that in remissive subjects (0.3114). Evaluation of two other independent datasets yielded similar results. Moreover, we found that the score significantly positively correlated with the degree of dysplasia in the case of colorectal adenomas. In the merged dataset, the median incidence risk score was 0.9027 among high-grade adenoma samples, significantly higher than that among low-grade adenomas (0.8565). In summary, the developed incidence risk score could well predict the incidence risk of precancerous colorectal lesions and has value in clinical application.
format Online
Article
Text
id pubmed-7844367
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78443672021-01-30 A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions Guan, Qingzhou Zeng, Qiuhong Jiang, Weizhong Xie, Jiajing Cheng, Jun Yan, Haidan He, Jun Xu, Yang Guan, Guoxian Guo, Zheng Ao, Lu Front Genet Genetics It is meaningful to assess the risk of cancer incidence among patients with precancerous colorectal lesions. Comparing the within-sample relative expression orderings (REOs) of colorectal cancer patients measured by multiple platforms with that of normal colorectal tissues, a qualitative transcriptional signature consisting of 1,840 gene pairs was identified in the training data. Within an evaluation dataset of 16 active and 18 inactive (remissive) ulcerative colitis subjects, the median incidence risk score of colorectal carcinoma was 0.6402 in active ulcerative colitis subjects, significantly higher than that in remissive subjects (0.3114). Evaluation of two other independent datasets yielded similar results. Moreover, we found that the score significantly positively correlated with the degree of dysplasia in the case of colorectal adenomas. In the merged dataset, the median incidence risk score was 0.9027 among high-grade adenoma samples, significantly higher than that among low-grade adenomas (0.8565). In summary, the developed incidence risk score could well predict the incidence risk of precancerous colorectal lesions and has value in clinical application. Frontiers Media S.A. 2021-01-15 /pmc/articles/PMC7844367/ /pubmed/33519891 http://dx.doi.org/10.3389/fgene.2020.573787 Text en Copyright © 2021 Guan, Zeng, Jiang, Xie, Cheng, Yan, He, Xu, Guan, Guo and Ao. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Guan, Qingzhou
Zeng, Qiuhong
Jiang, Weizhong
Xie, Jiajing
Cheng, Jun
Yan, Haidan
He, Jun
Xu, Yang
Guan, Guoxian
Guo, Zheng
Ao, Lu
A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions
title A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions
title_full A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions
title_fullStr A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions
title_full_unstemmed A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions
title_short A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions
title_sort qualitative transcriptional signature for the risk assessment of precancerous colorectal lesions
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844367/
https://www.ncbi.nlm.nih.gov/pubmed/33519891
http://dx.doi.org/10.3389/fgene.2020.573787
work_keys_str_mv AT guanqingzhou aqualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT zengqiuhong aqualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT jiangweizhong aqualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT xiejiajing aqualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT chengjun aqualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT yanhaidan aqualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT hejun aqualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT xuyang aqualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT guanguoxian aqualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT guozheng aqualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT aolu aqualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT guanqingzhou qualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT zengqiuhong qualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT jiangweizhong qualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT xiejiajing qualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT chengjun qualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT yanhaidan qualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT hejun qualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT xuyang qualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT guanguoxian qualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT guozheng qualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions
AT aolu qualitativetranscriptionalsignaturefortheriskassessmentofprecancerouscolorectallesions